Highlights and Quick Summary
- Annual Depreciation/Fixed assets for 2021 was 0.11 (a -11.76% decrease from previous year)
- Annual Depreciation/Fixed assets for 2020 was 0.12 (a -59.23% decrease from previous year)
- Annual Depreciation/Fixed assets for 2019 was 0.29 (a -13.53% decrease from previous year)
- Twelve month Depreciation/Fixed assets ending September 30, 2022 was 0.17 (a 24.91% increase compared to previous quarter)
- Twelve month trailing Depreciation/Fixed assets increased by 58.32% year-over-year
Trailing Depreciation/Fixed assets for the last four month:
| 30 Sep '22 | 30 Jun '22 | 31 Mar '22 | 31 Dec '21 |
|---|---|---|---|
| 0.17 | 0.13 | 0.13 | 0.11 |
Visit stockrow.com/BCEL
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Depreciation/Fixed assets of Atreca, Inc.
Most recent Depreciation/Fixed assetsof BCEL including historical data for past 10 years.Interactive Chart of Depreciation/Fixed assets of Atreca, Inc.
Atreca, Inc. Depreciation/Fixed assets for the past 10 Years (both Annual and Quarterly)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2021 | – | – | – | – | 0.11 |
| 2020 | – | – | – | – | 0.12 |
| 2019 | – | – | – | – | 0.29 |
| 2018 | – | – | – | – | 0.34 |
| 2017 | – | – | – | – | 0.32 |
Business Profile of Atreca, Inc.
Sector: Healthcare
Industry: Biotechnology